Kesimpta, Pluvicto, Scemblix, Kisqali, Leqvio and Fabhalta should fuel growth. NVS is a #3 (Hold) on the Zacks Rank, with a VGM Score of B. Momentum investors should take note of this Medical stock.

Below is Validea's guru fundamental report for NOVARTIS AG (ADR) (NVS). Of the 22 guru strategies we follow, NVS rates highest using our Multi-Factor Investor model based on the published strategy ...